Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Trends of cancer-associated venous thromboembolism (VTE) in the United States (2005-2014).

Almohammed OA, Lai L, Khanfar NM, Bleidt B, Aljadhey H.

Thromb Res. 2019 Oct;182:110-115. doi: 10.1016/j.thromres.2019.08.013. Epub 2019 Aug 19.

PMID:
31476484
2.

Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.

Aldryhim AY, Alomair A, Alqhtani M, Mahmoud MA, Alshammari TM, Pont LG, Kamal KM, Aljadhey H, Mekonnen AB, Alwhaibi M, Balkhi B, Alhawassi TM.

Expert Opin Drug Saf. 2019 Aug;18(8):745-752. doi: 10.1080/14740338.2019.1632287. Epub 2019 Jul 11.

PMID:
31232612
3.

A Qualitative Approach to Improving Advanced Pharmacy Practice Experiences in an ACPE International Certified Program.

Sales I, Mahmoud MA, Aljadhey H, Almeshal NI.

Am J Pharm Educ. 2019 Mar;83(2):6528. doi: 10.5688/ajpe6528.

4.

Medication adherence among patients with Type 2 diabetes: A mixed methods study.

Aloudah NM, Scott NW, Aljadhey HS, Araujo-Soares V, Alrubeaan KA, Watson MC.

PLoS One. 2018 Dec 11;13(12):e0207583. doi: 10.1371/journal.pone.0207583. eCollection 2018.

5.

Systematic review of the safety of medication use in inpatient, outpatient and primary care settings in the Gulf Cooperation Council countries.

Alsaidan J, Portlock J, Aljadhey HS, Shebl NA, Franklin BD.

Saudi Pharm J. 2018 Nov;26(7):977-1011. doi: 10.1016/j.jsps.2018.05.008. Epub 2018 May 23. Review.

6.

Corrigendum to "Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia" [Saudi Pharm. J. 22(5) (2014) 411-418].

Mahmoud MA, Alsowaida Y, Alshammari T, Khan TM, Alrasheedy A, Hasssali MA, Aljadhey H.

Saudi Pharm J. 2018 Jan;26(1):144. doi: 10.1016/j.jsps.2017.07.009. Epub 2017 Dec 6.

7.

Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010-2015.

Alshammari TM, Ata SI, Mahmoud MA, Alhawassi TM, Aljadhey HS.

Ther Clin Risk Manag. 2018 May 1;14:803-809. doi: 10.2147/TCRM.S161148. eCollection 2018.

8.
9.
10.

Medication safety officer preparatory course: Outcomes and experiences.

Aljadhey H, Alkhani S, Khan TM.

Saudi Pharm J. 2017 Nov;25(7):1011-1014. doi: 10.1016/j.jsps.2017.03.002. Epub 2017 Apr 4.

11.

Factors contributing to medicine-related problems in adult patients with diabetes and/or cardiovascular diseases in Saudi Arabia: a qualitative study.

Al Hamid AM, Ghaleb M, Aljadhey H, Aslanpour Z.

BMJ Open. 2017 Nov 12;7(11):e017664. doi: 10.1136/bmjopen-2017-017664.

12.

Prevalence and Factors Associated With Polypharmacy Use Among Adult Patients in Saudi Arabia.

Balkhi B, AlQahtani N, Alwhaibi M, Alshammari TM, Alhawassi TM, Mahmoud MA, Almetwazi M, Ata S, Basyoni M, Aljadhey H.

J Patient Saf. 2017 Oct 30. doi: 10.1097/PTS.0000000000000439. [Epub ahead of print]

PMID:
29087978
13.

Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.

Sales I, Aljadhey H, Albogami Y, Mahmoud MA.

Saudi Pharm J. 2017 Sep;25(6):868-872. doi: 10.1016/j.jsps.2017.01.004. Epub 2017 Jan 25.

14.

Vaccine on-demand service: One shot or a sustainable prevention?

Balkhi BS, Aljadhey H, Alhawassi TM.

Saudi Pharm J. 2017 Jul;25(5):816-817. doi: 10.1016/j.jsps.2016.10.007. Epub 2016 Oct 17. No abstract available.

15.

A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.

Hashmi FK, Hassali MA, Khalid A, Saleem F, Aljadhey H, Babar ZUD, Bashaar M.

BMC Health Serv Res. 2017 Jul 19;17(1):500. doi: 10.1186/s12913-017-2442-6.

16.

Patients' understanding of prescription drug label instructions in developing nations: The case of Saudi Arabia.

Alburikan KA, AbuAlreesh A, Alenazi M, Albabtain H, Alqouzi M, Alawaji M, Aljadhey HS.

Res Social Adm Pharm. 2018 May;14(5):413-417. doi: 10.1016/j.sapharm.2017.05.004. Epub 2017 May 16.

PMID:
28533081
17.

Evaluating the pictorial warnings on tobacco products in Arabian Gulf countries against other international pictorial warnings.

BinDhim NF, McGeechan K, Alanazi AKT, Alanazi HMS, Alanazi SAJ, Al-Hadlaq SM, Aljadhey H, Alhawassi TM, Alghamdi NA, Shaman AM, Alquwayzani MS, Basyouni MH.

Tob Control. 2017 May 12. pii: tobaccocontrol-2016-053323. doi: 10.1136/tobaccocontrol-2016-053323. [Epub ahead of print]

PMID:
28500119
18.

Pharmacovigilance system in Saudi Arabia.

Alshammari TM, Alshakka M, Aljadhey H.

Saudi Pharm J. 2017 Mar;25(3):299-305. doi: 10.1016/j.jsps.2016.09.008. Epub 2016 Sep 30. Review.

19.

Pharmacy education in Saudi Arabia: A vision of the future.

Aljadhey H, Asiri Y, Albogami Y, Spratto G, Alshehri M.

Saudi Pharm J. 2017 Jan;25(1):88-92. doi: 10.1016/j.jsps.2016.02.001. Epub 2016 Feb 20.

20.

Association Between Diabetes-related Knowledge and Medication Adherence: Results From Cross-sectional Analysis.

Nazir SU, Hassali MA, Saleem F, Bashir S, Aljadhey H.

Altern Ther Health Med. 2016 Nov;22(6):8-13.

PMID:
27866175
21.

Implementation of safety standards of compounded sterile preparations in hospital pharmacies: a multinational cross-sectional study.

Al-Fadel N, Mahmoud MA, Dabliz R, Tabbara O, Aljadhey H.

Eur J Hosp Pharm. 2016 Nov;23(6):339-342. doi: 10.1136/ejhpharm-2015-000872. Epub 2016 Mar 21.

22.

An assessment of the basic medication safety practices in Khartoum State hospitals.

Abdulrahman SS, Mahmoud MA, Ibrahim A, Aljadhey H.

Eur J Hosp Pharm. 2016 Nov;23(6):335-338. doi: 10.1136/ejhpharm-2016-000885. Epub 2016 Mar 14.

23.

Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with type 2 diabetes.

Tourkmani AM, Hassali MA, Alharbi TJ, Alkhashan HI, Alobikan AH, Bakhiet AH, Alqahtani HB, Alrasheedy AA, Alawwad AD, Mishriky AM, Aljadhey H.

Patient Prefer Adherence. 2016 Sep 6;10:1709-17. doi: 10.2147/PPA.S113324. eCollection 2016.

25.

Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study.

Aljadhey H, Mahmoud MA, Ahmed Y, Sultana R, Zouein S, Alshanawani S, Mayet A, Alshaikh MK, Kalagi N, Al Tawil E, El Kinge AR, Arwadi A, Alyahya M, Murray MD, Bates D.

BMJ Open. 2016 Jul 12;6(7):e010831. doi: 10.1136/bmjopen-2015-010831.

26.

Does a Mobile Phone Depression-Screening App Motivate Mobile Phone Users With High Depressive Symptoms to Seek a Health Care Professional's Help?

BinDhim NF, Alanazi EM, Aljadhey H, Basyouni MH, Kowalski SR, Pont LG, Shaman AM, Trevena L, Alhawassi TM.

J Med Internet Res. 2016 Jun 27;18(6):e156. doi: 10.2196/jmir.5726.

27.

Hospitalisation Resulting from Medicine-Related Problems in Adult Patients with Cardiovascular Diseases and Diabetes in the United Kingdom and Saudi Arabia.

Al Hamid A, Aslanpour Z, Aljadhey H, Ghaleb M.

Int J Environ Res Public Health. 2016 May 9;13(5). pii: E479. doi: 10.3390/ijerph13050479.

28.

Corrigendum to "Medication safety practices in hospitals: A national survey in Saudi Arabia" [Saudi Pharm. J. 21(2) (2013) 159-164].

Aljadhey H, Alhossan A, Alburikan K, Adam M, Murray MD, Bates DW.

Saudi Pharm J. 2016 Mar;24(2):232. doi: 10.1016/j.jsps.2015.04.001. Epub 2015 Apr 24.

29.

Incorporating the concept of leadership in pharmacy curriculums of developing nations.

Saleem F, Hassali MA, Aljadhey H.

Res Social Adm Pharm. 2016 Jul-Aug;12(4):668. doi: 10.1016/j.sapharm.2016.02.011. Epub 2016 Mar 4. No abstract available.

PMID:
26997135
30.

A cross-sectional assessment of health-related quality of life among type 2 diabetic patients in Pakistan.

Nazir SU, Hassali MA, Saleem F, Bashir S, Hashmi F, Aljadhey H.

J Pharm Bioallied Sci. 2016 Jan-Mar;8(1):64-8. doi: 10.4103/0975-7406.171734.

31.

Pharmaceutical Pricing Policies and Procedures in Saudi Arabia: A Narrative Review.

Khan TM, Emeka P, Suleiman AK, Alnutafy FS, Aljadhey H.

Ther Innov Regul Sci. 2016 Mar;50(2):236-240. doi: 10.1177/2168479015609648.

PMID:
30227009
32.

A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.

Shankar PR, Jha N, Aljadhey H, Pitts PJ.

Saudi Med J. 2015 Nov;36(11):1369-70. doi: 10.15537/smj.2015.11.13653. No abstract available.

33.

Disease related knowledge, medication adherence and glycaemic control among patients with type 2 diabetes mellitus in Pakistan.

Nazir SU, Hassali MA, Saleem F, Bashir S, Aljadhey H.

Prim Care Diabetes. 2016 Apr;10(2):136-41. doi: 10.1016/j.pcd.2015.09.004. Epub 2015 Oct 21.

PMID:
26476867
34.

Development, test-retest reliability and validity of the Pharmacy Value-Added Services Questionnaire (PVASQ).

Tan CL, Hassali MA, Saleem F, Shafie AA, Aljadhey H, Gan VB.

Pharm Pract (Granada). 2015 Apr-Jun;13(3):598. doi: 10.18549/PharmPract.2015.03.598. Epub 2015 Jun 15.

35.

A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.

Aljadhey H, Mahmoud MA, Alshammari TM, Al-Dhaeefi M, Le Louet H, Perez-Gutthann S, Pitts PJ.

Saudi Med J. 2015 Sep;36(9):1097-102. doi: 10.15537/smj.2015.9.12125.

36.

Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.

Alshammari TM, Alamri KK, Ghawa YA, Alohali NF, Abualkol SA, Aljadhey HS.

Int J Clin Pharm. 2015 Dec;37(6):1104-10. doi: 10.1007/s11096-015-0165-5. Epub 2015 Jul 28.

PMID:
26216270
37.

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system.

Alshammari TM, Al-Kathiri WH, Le Louet H, Aljadhey HS.

Saudi Med J. 2015 Jul;36(7):821-8. doi: 10.15537/smj.2015.7.11751.

38.

Self-medication in Central Saudi Arabia. Community pharmacy consumers' perspectives.

Aljadhey H, Assiri GA, Mahmoud MA, Al-Aqeel S, Murray M.

Saudi Med J. 2015 Mar;36(3):328-34. doi: 10.15537/smj.2015.3.10523.

39.

General practitioners' knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications.

Hassali MA, Kamil TK, Md Yusof FA, Alrasheedy AA, Yusoff ZM, Saleem F, Al-Tamimi SK, Wong ZY, Aljadhey H, Godman B.

Expert Rev Anti Infect Ther. 2015 Apr;13(4):511-20. doi: 10.1586/14787210.2015.1012497. Epub 2015 Feb 21.

40.

Patients' beliefs about generic medicines in Malaysia.

Wong ZY, Hassali MA, Alrasheedy AA, Saleem F, Yahaya AH, Aljadhey H.

Pharm Pract (Granada). 2014 Oct;12(4):474. Epub 2014 Mar 15.

41.

The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use.

Hassali MA, Alrasheedy AA, McLachlan A, Nguyen TA, Al-Tamimi SK, Ibrahim MI, Aljadhey H.

Saudi Pharm J. 2014 Dec;22(6):491-503. doi: 10.1016/j.jsps.2013.12.017. Epub 2013 Dec 25. Review.

42.

Factors contributing to the identification and prevention of incorrect drug prescribing errors in outpatient setting.

Al-Khani S, Moharram A, Aljadhey H.

Saudi Pharm J. 2014 Nov;22(5):429-32. doi: 10.1016/j.jsps.2013.11.003. Epub 2013 Nov 19.

43.

Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.

Mahmoud MA, Alsowaida Y, Alshammari T, Khan TM, Alrasheedy A, Hassali MA, Aljadhey H.

Saudi Pharm J. 2014 Nov;22(5):411-8. doi: 10.1016/j.jsps.2013.07.005. Epub 2013 Aug 21. Erratum in: Saudi Pharm J. 2018 Jan;26(1):144. Alswaida, Yazeed [corrected to Alsowaida, Yazed].

44.
45.

Health care professionals' awareness of, knowledge about and attitude to influenza vaccination.

Alshammari TM, AlFehaid LS, AlFraih JK, Aljadhey HS.

Vaccine. 2014 Oct 14;32(45):5957-61. doi: 10.1016/j.vaccine.2014.08.061. Epub 2014 Sep 11.

PMID:
25218193
46.

Prescribing errors incidence in hospitalized Saudi patients: Methodology considerations.

Mahmoud MA, Aljadhey H, Hassali MA.

Saudi Pharm J. 2014 Sep;22(4):388-9. doi: 10.1016/j.jsps.2014.04.003. No abstract available.

47.

Challenges to and the future of medication safety in Saudi Arabia: A qualitative study.

Aljadhey H, Mahmoud MA, Hassali MA, Alrasheedy A, Alahmad A, Saleem F, Sheikh A, Murray M, Bates DW.

Saudi Pharm J. 2014 Sep;22(4):326-32. doi: 10.1016/j.jsps.2013.08.001. Epub 2013 Sep 12.

48.

Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review.

Hassali MA, Wong ZY, Alrasheedy AA, Saleem F, Mohamad Yahaya AH, Aljadhey H.

Health Policy. 2014 Sep;117(3):297-310. doi: 10.1016/j.healthpol.2014.07.014. Epub 2014 Aug 1. Review.

PMID:
25129135
49.

Perceptions and attitudes of pharmacy students towards volunteering at health promotional programs: a cross-sectional study from Malaysia.

Saleem F, Hassali MA, Ibrahim ZS, Rasheedy AA, Aljadhey H.

J Community Health. 2015 Apr;40(2):285-90. doi: 10.1007/s10900-014-9930-y.

PMID:
25115271
50.

Reply to the letter regarding 'A systematic review of hospitalization resulting from medicine related problems in adult patients'.

Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z.

Br J Clin Pharmacol. 2014 Dec;78(6):1467-8. doi: 10.1111/bcp.12460. No abstract available.

Supplemental Content

Loading ...
Support Center